48,874
edits
Line 109: | Line 109: | ||
| some advocate grade 4<ref name=pmid14976541/> | | some advocate grade 4<ref name=pmid14976541/> | ||
|- | |- | ||
|Sarcomatoid carcinoma | | [[Sarcomatoid carcinoma of the prostate|Sarcomatoid carcinoma]] | ||
| 5 | | 5 | ||
| glands graded separately | | glands graded separately | ||
Line 117: | Line 117: | ||
| | | | ||
|- | |- | ||
|Small cell carcinoma | |[[Small cell carcinoma of the prostate gland|Small cell carcinoma]] | ||
| not graded (ISUP 2005 consensus<ref name=pmid16096414>{{Cite journal | last1 = Epstein | first1 = JI. | last2 = Allsbrook | first2 = WC. | last3 = Amin | first3 = MB. | last4 = Egevad | first4 = LL. | title = The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. | journal = Am J Surg Pathol | volume = 29 | issue = 9 | pages = 1228-42 | month = Sep | year = 2005 | doi = | PMID = 16096414 }}</ref>) | | not graded (ISUP 2005 consensus<ref name=pmid16096414>{{Cite journal | last1 = Epstein | first1 = JI. | last2 = Allsbrook | first2 = WC. | last3 = Amin | first3 = MB. | last4 = Egevad | first4 = LL. | title = The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. | journal = Am J Surg Pathol | volume = 29 | issue = 9 | pages = 1228-42 | month = Sep | year = 2005 | doi = | PMID = 16096414 }}</ref>) | ||
| may be graded 5<ref name=bostwicklabs/> | | may be graded 5<ref name=bostwicklabs/> |
edits